Skip to main content
. 2020 Sep 16;286:113974. doi: 10.1016/j.jviromet.2020.113974

Table 1.

The clinical dada of patients in this study.

Group Number [% (95 % CI)] Age + SD Hospitalization time + SD
Total 47 53.45 ± 12.08 36.81 ± 3.16
Common 32 [68.09 (53.84−79.61)] 52 ± 11.44 36 ± 3
Heavy 12 [25.53 (15.25−39.51)] 51.25 ± 11.08 39.08 ± 2.60
Sever 3 [6.38 (2.19−17.16)] 77.67 ± 7.11 36.33 ± 1.78
Male 22 [46.81 (33.33−60.77)] 54.32 ± 12.86 36.18 ± 3.65
Common 15 [68.18 (47.32−83.63)] 53.67 ± 12.22 35 ± 3.47
Heavy 6 [27.27 (13.15−48.15)] 51 ± 11.67 39.5 ± 3.25
Sever 1 [4.55 (0.81−21.8)] 84 ± 0 34 ± 0
Female 25 [53.19 (39.23−66.67)] 52.68 ± 11.40 37.36 ± 2.72
Common 17[68 (48.41−82.79)] 50.53 ± 10.79 36.88 ± 2.57
Heavy 6[24 (11.5−43.43)] 51.5 ± 10.5 38.67 ± 2.78
Sever 2[8 (2.22−24.97)] 74.5 ± 7.5 37.5 ± 1.5